Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
Roswell Park Cancer Institute
Roswell Park Cancer Institute
University of Michigan Rogel Cancer Center
Heinrich-Heine University, Duesseldorf
M.D. Anderson Cancer Center
University of Nebraska
Memorial Sloan Kettering Cancer Center
Alliance for Clinical Trials in Oncology
Regimmune Corporation
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
Targazyme, Inc.
Asan Medical Center